Skip to main content
  • Booster Shots Could Start September 20

    Credit: FOX-46 Dr. Anthony Fauci, America’s top infectious disease expert, said he believes booster shots will be available for Americans starting Sept. 20 – but not everyone will be able to get a dose right away. David Wohl, MD, professor of medicine in the division of infectious diseases, answered questions about booster shots on FOX-46, Good Day Charlotte. Watch the segment.

  • david-wohl-discussing-mandate-removal-ABC 11

    September Could Be Worst Month For COVID Hospitalizations Yet

    David Wohl, MD WRAL reports that evidence is mounting to show the fight against COVID-19 in North Carolina could be about to enter uncharted waters. “We’re in the place we are now, a place of surge, a place of pain, a place of chaos, because, to be truthful, we have so many people unvaccinated,” said David Wohl, MD, professor of medicine in the division of infectious diseases. “I … Read more

  • Shakira_Grant-1-200x300

    Grant Receives $200,000 to Study Impact of Multiple Myeloma on Older Adult Patients, Care Partners

    Shakira Grant, MBBS The National Institute on Aging has awarded Shakira Grant, MBBS, and the UNC Center for Aging and Health a 2-year, $200,000 grant to study the illness and treatment experiences and functional trajectories of older adults with multiple myeloma and their care partners. Grant is assistant professor in the divisions of hematology and geriatric medicine. Multiple m … Read more

  • Richard Boucher-new-mask-newsweek-article

    Carolina Researchers Lead CZI Collaborative on Childhood Diseases

    Richard Boucher, MD Principal investigators James Hagood, MD, professor of pediatrics and Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine will lead a multinational, $3.5-million project funded through the Chan Zuckerberg Initiative to map crucial cellular roles in human health and disease. The … Read more

  • Wohl-News-Interview-Credit-WTVD

    Should We Focus on Getting Vaccines For Kids or Booster Shots for Adults?

    Credit: WTVD-ABC 11 David Wohl, MD, professor of medicine in the division of infectious diseases, talked with ABC-11 about COVID-19 models and when cases might peak. He also answered questions about vaccines for kids and booster shots for adults. Watch the news story.

  • Jessica Lin, MD, MSCR

    Which Type of Immunity Is Best Against Variants? More Symptoms, More Spread and Other COVID-19 News

    Jessica Lin, MD MSCR An article in Infection Disease Special Edition reviews recent studies about COVID-19 transmission, including one led by Jessica Lin, MD, that showed COVID-19 spreads quickly through a household. The observational study, conducted between April and October 2020, followed 100 patients who tested positive for COVID-19 around the Raleigh, N.C., area and included … Read more

  • david-wohl-discussing-mandate-removal-ABC 11

    Cooper Promises Expanded Access to COVID Antibody Treatment

    David Wohl, MD On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a potentially lifesaving treatment designed to keep people out of the hospital in the first place. “We’ve been beating the drum for months now, since November of last year, … Read more

  • David Weber, MD, MPH

    How Safe Are Outdoor Events? Is a Lockdown Coming?

    David Weber, MD, MPH Eighteen months into the pandemic and there are still a lot of questions out there about everything related to COVID-19. CBS 17 took those questions to health experts to get answers using facts not fear. David Weber, MD, MPH, professor of medicine in the division of infectious diseases, contributed to the question and answer segment. Read or watch the report. … Read more

  • QA-David-Wohl

    Experimental Monoclonal Antibody Combo Shows Significant Efficacy Against COVID-19

    David Wohl, MD (Credit: TPAN) As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk patients. ACTIV-2 vice chair David Wohl, MD, leads monoclonal treatment for UNC Health. Read more from the UNC Health and UNC School … Read more

  • hobbs-duncan-STD-Awareness

    Hobbs and Duncan Win $3.9M NIAID Grant to Study a Meningitis Vaccine’s Effect on Gonorrhea

    Marcia Hobbs, PhD, and Alex Duncan, MD, PhD The NIH’s National Institute of Allergy and Infectious Diseases has awarded Marcia Hobbs, PhD, and Alex Duncan, MD, PhD, a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with … Read more

  • Jessica Lin, MD, MSCR

    Transmission Rate of COVID-19 Within Households Can Be Over 30%, More than 50% from Minority Communities

    Jessica Lin, MD MSCR With potent virulence and transmissibility, the SARS-CoV-2 virus is one of the deadliest pathogens to be encountered in recorded history. Scientists have reiterated that other than hygienic measures, distance between individuals is the best defense against its spread. However, the latter is difficult within a household and presents challenges in the event of … Read more

  • emily-sickbert-cbs-17-wearing-a-mask

    Mask Guidance Evolves Indoors and Outdoors as Delta Variant Keeps Spreading

    Emily Sickbert-Bennett, PhD, MS Precautions are changing as the highly contagious Delta variant spreads. Now, experts say even in outdoor settings, a mask is still strongly encouraged in many instances. The Director of Infection Prevention at UNC Medical Center, Emily Sickbert-Bennett, PhD, MS, understands the frustration. She says we now know much more about COVID-19, which is w … Read more